Biggest News Aggregation in the World
๐Ÿ“ฐ Jake Robison News

Jake Robison News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Jake Robison. Real-time updates on events, politics, business and more.

Nucleix Demonstrates Potential of its PCR EpiCheck® Assay to Accurately Differentiate Between Small Cell Lung Cancer (SCLC) Subtypes

SAN DIEGO & REHOVOT, Israel, April 04, 2024--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced data from a pilot study demonstrating the potential of a simple PCR assay based on EpiCheck® technology to accurately differentiate between small cell lung cancer (SCLC) subtypes. The Company is presenting the data in a poster presentation at the American Association for Cancer Research (AACR) Annual Meeting 2024 in San Diego, ...
United States San Diego Jake Robison Mathias Ehrich University Of Texas Md Anderson Cancer Center Nucleix Ltd
Source: yahoo.com

Daré Bioscience to Present at the 9th Annual International Symposium of Drug Delivery Systems - Dare Bioscience (NASDAQ:DARE)

SAN DIEGO, July 11, 2023 (GLOBE NEWSWIRE) -- Darรฉ Bioscience, Inc. (NASDAQ:DARE), a leader in women's health innovation, today announced that the company's Chief Scientific Officer, David Friend, Ph.D., will present
United States Massachusetts Institute Of Technology Noord Holland Jake Robison Robert Langer Lee Roth Julia Weilman

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Daré Bioscience Announces Upcoming Webinar to Review Additional Data from Exploratory Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder

Webinar to be held Tuesday, July 11, 2023, at 4:30 p.m. EDT Webinar to include presentations by Daré management and key opinion leaders in reproductive and sexual medicine SAN DIEGO, July ...
United Kingdom United States Dburns Mcclellan Sabrina Martucci Johnson Jamesa Simon Julia Weilman

Daré Bioscience Announces New Development Program, DARE-PDM1, as a Potential First-in-Category Treatment for Primary Dysmenorrhea

12.12.2022 - DARE-PDM1 Utilizes Proprietary Hydrogel Technology for Vaginal Delivery of Diclofenac, a Nonsteroidal Anti-Inflammatory; Phase 1 Study Targeted for 2023 2022 Darรฉ Portfolio Accomplishments Include: Two Additional Portfolio Programs (DARE-GML and ...
United States Dburns Mcclellan Sabrina Martucci Johnson Annie Thurman Jake Robison Lee Roth

Daré Bioscience, Inc. Announces Global Licensing Rights to the Novel Antimicrobial Glycerol Monolaurate for Vaginal Health

Darรฉ Bioscience, Inc. Announces Global Licensing Rights to the Novel Antimicrobial Glycerol Monolaurate for Vaginal Health - read this article along with other careers information, tips and advice on BioSpace
Dburns Mcclellan Sabrina Martucci Johnson Jake Robison Lee Roth Bioscience Inc University Of Minnesota

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science